Swiss Re Life & Health Australia will suspend new life insurance business in the country starting this month, while Hannover Life Re of Australasia progresses with a separate acquisition of the direct life insurance arm iptiQ. The sale price was not disclosed, and the deal remains subject to Federal Court of Australia and regulatory approvals, with an expected close within 18 months.
For Hannover, the acquisition aligns with its regional expansion strategy and is framed by executives as a vote of confidence in Australia’s direct life market. Swiss Re, by contrast, has chosen a different path, prioritizing existing customers and ongoing regulatory collaboration over pursuing new retail clients in Australia.
Market Dynamics Drive Strategic Pause
Executives cited shifting workplace realities, rising claim costs, and evolving consumer expectations as core reasons behind the pause. Total permanent disability (TPD) cover, in particular, is highlighted as an area needing urgent redesign. Industry data supports concerns about rising TPD costs: the Council of Australian Life Insurers reported that in 2024, payouts tied to mental health-related TPD claims exceeded A$2.2 billion, nearly double the amount from five years earlier. Insurers warn that these pressures are affecting the financial system.
Swiss Re emphasized that it will not pursue new retail clients until the market demonstrates progress toward sustainable products. The strategy instead focuses on strengthening relationships with existing customers, regulators, and industry peers, with a aim to develop products aligned with social change and clearer financial certainty for Australians.
Leadership Perspectives on Reform and Sustainability
Paul Murray, Swiss Re’s chief executive for global life and health reinsurance, described the situation as “a chance for renewal,” noting the challenge of balancing the social value of TPD with the need to keep premiums affordable.
Lloyd Campbell Gibson, who oversees life and health reinsurance in Australia and New Zealand, argued for a broader view beyond mere claim payments. “We need to partner with people across their health journey,” he said. He suggested that evidence-driven product adjustments could make TPD more adaptive and accessible for future generations.
Gibson also stated the company’s commitment to Australia and New Zealand markets remains steadfast, describing the pause as a defensive measure to protect the portfolio and advocate for reform in product design. He noted that, unlike Australia, Swiss Re’s New Zealand retail life insurance engagement will continue without interruption, with ongoing focus on protecting individuals while maintaining long-term sustainability of disability products.
Path Forward and Implications
Executives stressed that the group remains dedicated to both markets, and the pause in Australia is framed as necessary to safeguard the portfolio and push for overdue reform in product design. The developments signal a broader industry emphasis on sustainable product structures and collaboration among insurers, regulators, and health services to manage rising disability costs.
The strategic moves, including Hannover’s acquisition and Swiss Re’s pause, illustrate a two-pronged approach to maintaining market presence while addressing systemic cost pressures and evolving consumer expectations in life and disability insurance.
Related topics
